While GLP-1 is most known for its weight loss effects , its also a powerful hormone for metabolic health, brain function, gut healing, and heart protection
Moreover, food-seeking behaviors may intensify due to the rewarding nature of highly palatable foods, a process called operant conditioning (like training ourselves to want certain things)
The mechanisms driving these lipid changes involve both direct metabolic effects and weight loss consequences
Use: To reduce the risk of sustained estimated eGFR decline, ESRD, and CV death in patients with type 2 diabetes mellitus and chronic kidney disease Usual Adult Dose for Metabolic Dysfunction-Associated Steatohepatitis Wegovy injection: Initial dose (weeks 1 through 4): 0.25 mg subcutaneously once a week Dose escalation: Weeks 5 through 8: 0.5 mg subcutaneously once a week Weeks 9 through 12: 1 mg subcutaneously once a week Weeks 13 through 16: 1.7 mg subcutaneously once a week If 2.4 mg is not tolerated: 1.7 mg subcutaneously once a week
However, the carbonic anhydrase 8 (CAR8), which is highly expressed in L-cells, has been found to reduce GLP-1 secretion in response to LCFAs